加速康复外科理念下胫骨平台骨折诊疗方案优化的专家共识

2020-10-30 中国骨科相关专家小组(统称) 中华创伤骨科杂志.2020.22(10):829-840

ERAS理念的引入,可以为胫骨平台骨折的诊治提供更全面的平台,也为诊疗方法的选择和优化提供了更为明确的导向和标准。因此,经全国创伤骨科专家代表讨论,在循证医学基础上,以ERAS理念为指导,特制定本共识

中文标题:

加速康复外科理念下胫骨平台骨折诊疗方案优化的专家共识

发布日期:

2020-10-30

简要介绍:

ERAS理念的引入,可以为胫骨平台骨折的诊治提供更全面的平台,也为诊疗方法的选择和优化提供了更为明确的导向和标准。因此,经全国创伤骨科专家代表讨论,在循证医学基础上,以ERAS理念为指导,特制定本共识。该共识适用于成年人新鲜闭合性胫骨平台骨折(手术距伤后3周内)患者。

下载附件:

(因为版权问题,不支持下载)

评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1214700, encodeId=65861214e00f5, content=***, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 19:34:11 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082456, encodeId=01c01082456a7, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211220/34dc3395cbdc499d89c489c063269dd6/050ea6ea2df143eaa7f141a7ebb4d0bc.jpg, createdBy=94156413226, createdName=洁巴子, createdTime=Tue Dec 21 09:17:41 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008482, encodeId=0af81008482e2, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc8d5457214, createdName=悠然66, createdTime=Mon Aug 16 22:34:12 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003417, encodeId=f268100341eac, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f91a5555640, createdName=ms5000000338064393, createdTime=Wed Jul 28 20:15:57 CST 2021, time=2021-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905461, encodeId=dd96905461fd, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b70e1587992, createdName=2636925255, createdTime=Sun Dec 06 18:36:37 CST 2020, time=2020-12-06, status=1, ipAttribution=)]
    2022-04-26 su_yi_fei

    ***

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1214700, encodeId=65861214e00f5, content=***, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 19:34:11 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082456, encodeId=01c01082456a7, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211220/34dc3395cbdc499d89c489c063269dd6/050ea6ea2df143eaa7f141a7ebb4d0bc.jpg, createdBy=94156413226, createdName=洁巴子, createdTime=Tue Dec 21 09:17:41 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008482, encodeId=0af81008482e2, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc8d5457214, createdName=悠然66, createdTime=Mon Aug 16 22:34:12 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003417, encodeId=f268100341eac, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f91a5555640, createdName=ms5000000338064393, createdTime=Wed Jul 28 20:15:57 CST 2021, time=2021-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905461, encodeId=dd96905461fd, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b70e1587992, createdName=2636925255, createdTime=Sun Dec 06 18:36:37 CST 2020, time=2020-12-06, status=1, ipAttribution=)]
    2021-12-21 洁巴子

    好文章

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1214700, encodeId=65861214e00f5, content=***, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 19:34:11 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082456, encodeId=01c01082456a7, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211220/34dc3395cbdc499d89c489c063269dd6/050ea6ea2df143eaa7f141a7ebb4d0bc.jpg, createdBy=94156413226, createdName=洁巴子, createdTime=Tue Dec 21 09:17:41 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008482, encodeId=0af81008482e2, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc8d5457214, createdName=悠然66, createdTime=Mon Aug 16 22:34:12 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003417, encodeId=f268100341eac, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f91a5555640, createdName=ms5000000338064393, createdTime=Wed Jul 28 20:15:57 CST 2021, time=2021-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905461, encodeId=dd96905461fd, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b70e1587992, createdName=2636925255, createdTime=Sun Dec 06 18:36:37 CST 2020, time=2020-12-06, status=1, ipAttribution=)]
    2021-08-16 悠然66

    好文章

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1214700, encodeId=65861214e00f5, content=***, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 19:34:11 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082456, encodeId=01c01082456a7, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211220/34dc3395cbdc499d89c489c063269dd6/050ea6ea2df143eaa7f141a7ebb4d0bc.jpg, createdBy=94156413226, createdName=洁巴子, createdTime=Tue Dec 21 09:17:41 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008482, encodeId=0af81008482e2, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc8d5457214, createdName=悠然66, createdTime=Mon Aug 16 22:34:12 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003417, encodeId=f268100341eac, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f91a5555640, createdName=ms5000000338064393, createdTime=Wed Jul 28 20:15:57 CST 2021, time=2021-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905461, encodeId=dd96905461fd, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b70e1587992, createdName=2636925255, createdTime=Sun Dec 06 18:36:37 CST 2020, time=2020-12-06, status=1, ipAttribution=)]
    2021-07-28 ms5000000338064393

    好文章

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1214700, encodeId=65861214e00f5, content=***, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=427d4785086, createdName=su_yi_fei, createdTime=Tue Apr 26 19:34:11 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082456, encodeId=01c01082456a7, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211220/34dc3395cbdc499d89c489c063269dd6/050ea6ea2df143eaa7f141a7ebb4d0bc.jpg, createdBy=94156413226, createdName=洁巴子, createdTime=Tue Dec 21 09:17:41 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008482, encodeId=0af81008482e2, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc8d5457214, createdName=悠然66, createdTime=Mon Aug 16 22:34:12 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003417, encodeId=f268100341eac, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f91a5555640, createdName=ms5000000338064393, createdTime=Wed Jul 28 20:15:57 CST 2021, time=2021-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=905461, encodeId=dd96905461fd, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b70e1587992, createdName=2636925255, createdTime=Sun Dec 06 18:36:37 CST 2020, time=2020-12-06, status=1, ipAttribution=)]
    2020-12-06 2636925255

    好文章

    0

拓展阅读

2017 ASER/POQI共识声明:结直肠手术加速康复外科术后感染的预防

美国促进恢复学会(ASER,American Society for Enhanced Recovery) · 2017-03-03

胆道手术加速康复外科专家共识(2016版)

中国医师协会外科医师分会 · 2017-01-15

2017 ASER/POQI联合共识声明:加速择期结直肠癌手术康复术后胃肠功能紊乱

美国促进恢复学会(ASER,American Society for Enhanced Recovery) · 2017-12-29

加速康复外科中国专家共识暨路径管理指南(2018)

中华医学会外科学分会 · 2018-01-30

加速康复外科理念下桡骨远端骨折诊疗方案优化的专家共识

中国医疗保健国际交流促进会 · 2019-02-20